The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).
LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...
SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC) (the 'Company') today announced that it has engaged a Clinical Research Organization (CRO) to conduct a ...
The Healthy on MSN5h
What’s That Rash? How to ID 14 of the Most Common Skin IrritationsFeeling a little itchy? Here's how to recognize the most commonly undiagnosed skin irritations, including the one you may ...
GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...
GSK has announced that the European Medicines Agency (EMA) has accepted its regulatory application for a prefilled syringe presentation of Shingrix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback